Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children. Issue 8 (December 2020)

• Record Type: Journal Article
• Authors: Tchidjou, Hyppolite Kuekou; Caron, Fiorella; Ferec, Adeline; Braun, Karine; Hery, Loic; Castelain, Sandrine; Romeo, Bernard
• Is Part Of: Blood coagulation and fibrinolysis. Volume 31:Issue 8(2020)
• Publication Date: 2020-12
• Subjects: alkaline phosphatase -- case report -- coronavirus-2019 -- severe acute respiratory syndrome coronavirus 2 infection in children -- transient hyperphosphatasemia; Blood -- Coagulation -- Periodicals; Fibrinolysis -- Periodicals; Hemostasis -- Periodicals; Thrombosis -- Periodicals; Blood Coagulation -- Periodicals; Fibrinolysis -- Periodicals; Hemostasis -- Periodicals; Thrombosis -- Periodicals; 612.115
• DOI: 10.1097/MBC.0000000000000954
• Languages: English
• ISSNs: 0957-5235

Abstract

Abstract : N/A: It is now known that SARS-CoV-2 infection because of coronavirus is highly contagious and caused varying degrees of illness throughout the world. Hepatic dysfunction and the slight elevation of liver enzymes have been reported in cases of COVID-19 infection. Transient hyperphosphatasemia is a benign condition characterized by the elevation of serum alkaline phosphatase and the return to normal levels within weeks or months of first observation. We reported the first infant case of severe hyperphosphatasemia because of SARS-CoV-2 infection, in a 9-month-old child admitted to the Pediatric Covid-19 Unit of Amiens University Hospital. Given the hepatic tropism and COVID-19-related hyperinflammatory reactions, our case suggests that, an isolated severe hyperphosphatasemia in children with SARS-CoV-2 infection should increase the possibility of transient hyperphosphatasemia, even if is also demonstrated a classic natural history of the transient hyperphosphatasemia during viral infection, especially in SARS-CoV-2 infection.